Dynavax Technologies
DVAX
#4822
Rank
NZ$3.12 B
Marketcap
NZ$26.64
Share price
0.00%
Change (1 day)
10.75%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.48 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is NZ$0.48 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.45 B11.04%
2023-12-31NZ$0.40 B-0.03%
2022-12-31NZ$0.40 B7.84%
2021-12-31NZ$0.37 B24.81%
2020-12-31NZ$0.30 B-6.06%
2019-12-31NZ$0.32 B113.71%
2018-12-31NZ$0.15 B
2014-12-31NZ$12.2 M
2012-12-31N/A-100%
2011-12-31NZ$16.41 M7.48%
2010-12-31NZ$15.27 M-10.42%
2009-12-31NZ$17.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
NZ$104.57 B 21,248.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$93.81 B 19,051.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$11.30 B 2,207.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$42.86 B 8,650.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$71.10 B 14,415.97%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$50.90 B 10,292.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$41.00 B 8,271.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
NZ$78.66 M-83.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.37 B 5,897.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel